Design and Synthesis of Some New Theophylline Derivatives with Bronchodilator and Antibacterial Activities

다국어 초록 (Multilingual Abstract)

Methylxanthines especially theophylline have been recognized as potent bronchodilators for the relief of acute asthma for over 65 years. Recently, it was found that bacterial infection plays a role in asthma pathogenesis. Accordingly, the present work involves the synthesis of 6-(4-(un)substituted phenyl)thiazolo[2,3-f]theophyllines 2a-g and different series of 8-(1,2,4-triazol-3-ylmethylthio)theophyllines 6-9. The chemical structures of the target compounds were proved by IR, 1H NMR, 13C NMR, EI-MS and HRMS spectroscopic techniques along with elemental analyses. The bronchodilator activity of fifteen compounds was determined in vivo by acetylcholine induced bronchospasm in anaesthetized guinea pigs. Results revealed that all compounds showed moderate to good activity; in addition, five compounds exhibited a bronchodilator activity nearly similar to that of aminophylline as a standard. The antibacterial activity of all the target compounds was investigated in vitro against both Gram-positive and Gram-negative bacterial strains. Results revealed that some compounds showed more potent antibacterial activity than ampicillin as a standard. Acute toxicity study for four target compounds revealed that none of these derivatives showed significant toxicity up to 300 mg/kg. It was found that compound 8c combined both promising bronchodilator and antibacterial activities. This compound could be subjected for further investigations as a new possible candidate in the treatment of bronchial asthma.

참고문헌 (Reference)

1 Black, P. N., "Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae" 164 : 536-541, 2001

2 Ellis, E. F., "Theophylline, in Allergic Diseases Diagnosis and Treatment" Humana Press Inc 343-359, 2007

3 Johnston, S. L., "The effect of telithromycin in acute exacerbations of asthma" 354 : 1589-1600, 2006

4 Sandlie, I., "The effect of caffeine on cell growth and metabolism of thymidine in Escherichia coli" 73 : 29-41, 1980

5 Pajkert, R., "The amination of difluoro(diethoxyphosphoryl)acetyl chloride: facile synthetic route to novel amides containing difluoromethylenephosphonate moiety" 130 : 695-701, 2009

6 Peikov, P. T., "Synthesis, toxicological and pharmacological assessment of 7-substituted derivatives of 1,3-dimethylxanthine" 29 : 295-299, 1994

7 Elgaher, W. A., "Synthesis, anti-bronchoconstrictive, and antibacterial activities of some new 8-substituted-1,3-dimethylxanthine derivatives" 32 : 153-187, 2009

8 Ashour, F. A., "Synthesis of some 4-arylideneamino-5-mercapto-1,2,4-triazole, 1,2,4- triazolothiadiazole and 1,2,4-triazolothiadiazine derivatives of theophylline as antimicrobial agents" 7 : 127-130, 1993

9 Hayallah, A. M., "Synthesis of new 1,3,8-trisubstituted purine-2,6-diones and 1,3,6-trisubstituted thiazolo[ 2,3-f]purine-2,4-diones" 74 : 369-382, 2007

10 Romanenko, N. I., "Synthesis and study of antibacterial and antifungal activity of some 3-methyl-8-nitroxanthine derivatives" 31 : 189-190, 1997

11 Baziard-Mouysset, G., "Synthesis and in vitro bronchospasmolytic activity of 8- aryl, heteroaryl or arylalkyl theophyllines" 30 : 253-260, 1995

12 Strokin, Y. V., "Synthesis and biological activity of heterylaceto- and – thioacetohydrazide derivatives" 24 : 493-496, 1990

13 Karthikeyan, M. S., "Synthesis and antimicrobial studies of novel dichlorofluorophenyl containing aminotriazolothiadiazines" 43 : 309-314, 2008

14 Dianov, V. M., "Synthesis and antimicrobial activity of 3-methyl-substituted 6,8-dimethylthiazolo [2,3-f]xanthines" 40 : 551-553, 2006

15 Grosa, G., "Synthesis and antibronchospastic activity of theophylline thioacetal derivatives" 24 : 635-638, 1989

16 Uno, H., "Syntheses of thiazolo[2,3-f] theophyllines and their mass spectrometry" 20 : 2603-2606, 1972

17 Ochiai, E., "Synthese von thiazolo-imidazol- und thiazolopurin- derivaten" 69B : 1650-1655, 1936

18 Holla, B. S., "Studies on arylfuran heterocycles. Part-I. synthesis of 6-(5-aryl-2-furyl)-1,2,4-triazolo [3,4-b]-1,3,4-thiadiazoles" 68 : 341-343, 1991

19 Nafisi, S., "Structural features of DNA interaction with caffeine and theophylline" 875 : 392-399, 2008

20 Silverstein, R. M., "Spectrometric Identification of Organic Compounds" John Wiley & Sons 105-106, 2005

21 Kesler, B. S., "Regulation of baseline cholinergic tone in guinea-pig airway smooth muscle" 518 : 843-855, 1999

22 Yurchenko, M. I., "Reaction of 8-thiotheophylline with α-halo ketones. Chem. Heterocycl" 10 : 600-603, 1974

23 Johnson, I. M., "RNA binding efficacy of theophylline, theobromine and caffeine" 20 : 687-692, 2003

24 Baraldi, P. G., "Novel 8-heterocyclic xanthine derivatives in drug development – an update" 2 : 1161-1183, 2007

25 Regnier, G. L., "New xanthine derivatives with potent and long lasting anti-bronchoconstrictive activity" 22 : 243-250, 1987

26 Berk, B., "New 8-substituted xanthine derivatives as potent bronchodilators" 60 : 974-980, 2005

27 Kraft, M., "Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma effect of clarithromycin" 121 : 1782-1788, 2002

28 Hewitt, W., "Microbiological Assay an Introduction to Quantitative Principles and Evaluation" Academic Press 17-69, 1977

29 Scott, A. C., "Laboratory control of antimicrobial therapy, in Mackie & McCartney Practical Medical Microbiology" Churchill Livingstone 161-181, 1989

30 Labbe, R. G., "Inhibition of macromolecular synthesis by caffeine in Clostridium perfringens" 33 : 589-592, 1987

31 Karlsson, J.-A., "Effects on tracheal smooth muscle of adenosine and methylxanthines, and their interaction" 34 : 788-793, 1982

32 Raj, C. V. S., "Effect of naturally occurring xanthines on bacteria: I. Antimicrobial action and potentiating effect on antibiotic spectra" 13 : 432-436, 1965

33 Kraft, M., "Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma" 158 : 998-1001, 1998

34 El-Shorbagi, A. A., "Design and synthesis of some thiazolo[3,2-a]benzimidazole quaternary salts of potential antidiabetic activity" 24 : 7-20, 2001

35 Hayallah, A. M., "Design and synthesis of new 1,8-disubstituted purine-2,6-diones and 3,6-disubstituted thiazolo[2,3-f] purine-2,4-diones as potential antinociceptive and antiinflammatory agents" 54 : 3-13, 2007

36 Cunningham, A. F., "Chronic Chlamydia pneumoniae infection and asthma exacerbations in children" 11 : 345-349, 1998

37 Johnston, S. L., "Chlamydophila pneumoniae and Mycoplasma pneumoniae a role in asthma pathogenesis" 172 : 1078-1089, 2005

38 Cook, P. J., "Chlamydia pneumoniae and asthma" 53 : 254-259, 1998

39 Pérez, C., "Caffeine attenuates the action of amsacrine and etoposide in U-937 cells by mechanisms which involve inhibition of RNA synthesis" 57 : 889-893, 1994

40 Talbot, T. R., "Asthma as a risk factor for invasive pneumococcal disease" 352 : 2082-2090, 2005

41 Hahn, D. L., "Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma" 266 : 225-230, 1991

42 Black, P. N., "Antibiotics for the treatment of asthma" 7 : 266-271, 2007

43 Raeburn, D., "Anti-inflammatory and bronchodilator properties of RP73401, a novel and selective phosphodiesterase type IV inhibitor" 113 : 1423-1431, 1994

44 Akhila, J. S., "Acute toxicity studies and determination of median lethal dose" 93 : 917-920, 2007

45 Litchfield, J. T., "A simplified method of evaluating dose-effect experiments" 96 : 99-113, 1949

46 Karsovskii, A. N., "2,3-Dihydro-6,8-dimethylthiazolo[ 3,2-f]xanthin-3-one and its derivatives at the methylene group" 48 : 514-517, 1982